SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001539497-23-002188
Filing Date
2023-12-14
Accepted
2023-12-14 16:30:27
Documents
16
Period of Report
2023-12-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K n3936_x1-8k.htm   iXBRL 8-K 30368
2 INFORMATION STATEMENT OF BELLICUM PHARMACEUTICALS, INC., DATED DECEMBER 14, 2023 exh99-1.htm EX-99.1 1333715
6 GRAPHIC n3936img001.jpg GRAPHIC 12053
7 GRAPHIC pc1.jpg GRAPHIC 346876
8 GRAPHIC pc2.jpg GRAPHIC 436861
  Complete submission text file 0001539497-23-002188.txt   2843219

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE blcm-20231214.xsd EX-101.SCH 3015
4 XBRL LABEL FILE blcm-20231214_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE blcm-20231214_pre.xml EX-101.PRE 22359
10 EXTRACTED XBRL INSTANCE DOCUMENT n3936_x1-8k_htm.xml XML 3033
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 231487440
SIC: 2834 Pharmaceutical Preparations